Clinical trial

Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer

NCT02570919

Study summary

ClinicalTrials.gov

Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

RADIATION · Unmapped registry intervention IGRT 45 Gy in 5 fractions of 9 Gy Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention IGRT 24 Gy single dose Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-09-01

PhaseNA

Conditions

PROSTATE CANCERverified · MONDO: prostate cancer

Interventions

IGRT 45 Gy in 5 fractions of 9 GyRADIATION

IGRT 24 Gy single doseRADIATION

Sponsors & collaborators

Fundacao Champalimaudlead sponsor

Mapped research locations

LisbonPortugal1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02570919 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.